Neoteryx has been acquired by Trajan Group Holdings

Neoteryx, LLC has been sold to Trajan Group Holdings Limited.

Neoteryx, based in Southern California, is a global leader in blood micro-sampling, with operations in the USA and Europe. Its customers include scientific researchers, laboratories and health providers working to advance telemedicine, pharmaceutical development, biotechnology research and clinical diagnostics.

Trajan Group Holdings is a global developer and manufacturer of analytical and life sciences products and devices used in the analysis of biological, food, water and other environmental samples. The company has more than 520 employees, operating across the USA, Australia, Europe and Malaysia.

One of Oaklins’ teams in the USA served as the exclusive financial advisor to Neoteryx, LLC in this transaction.

Service

M&A sell-side

Parties

“At Neoteryx we developed innovative technology to transform specimen collection, and our goal was to achieve global commercial scale through a strategic transaction. The Oaklins team brought deep industry expertise and relationships to this assignment and a sharp focus on achieving our objectives. Our partnership with Trajan is an exciting outcome for the Neoteryx team and our customers as we together leverage micro-sampling to create advanced healthcare solutions.”

Fasha Mahjoor

Founder and CEO, Neoteryx, LLC

Talk to the deal team

Michael S. Goldman

Managing Director

New York, United States
Oaklins TM Capital

View profile Get in touch

James McLaren

Managing Director

New York, United States
Oaklins TM Capital

View profile Get in touch

John Dean

Associate Director

Atlanta, United States
Oaklins TM Capital

View profile Get in touch

Related deals

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Healthcare

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Learn more

Afric Phar has been acquired by Pharma Capital

Healthcare

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Learn more

Xiel Limited has been acquired by MIS Healthcare

Private Equity | Healthcare

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Learn more